Camber Capital Management LP Abb Vie Inc. Transaction History

Camber Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $88 Million - $118 Million	-1,200,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $77.4 Million - $117 Million	1,200,000 New	1,200,000 $91.4 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $36.1 Million - $45.1 Million	-500,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $31.5 Million - $37.9 Million	500,000 New	500,000 $37.9 Million

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.